Riedl et al., 2009 - Google Patents
Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potentialRiedl et al., 2009
- Document ID
- 10721003905233715425
- Author
- Riedl P
- Wieland A
- Lamberth K
- Buus S
- Lemonnier F
- Reifenberg K
- Reimann J
- Schirmbeck R
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
Immunodominance limits the TCR diversity of specific antiviral CD8 T cell responses elicited by vaccination or infection. To prime multispecific T cell responses, we constructed DNA vaccines that coexpress chimeric, multidomain Ags (with CD8 T cell-defined epitopes of the …
- 210000001744 T-Lymphocytes 0 title abstract description 64
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI555531B (en) | Composition for treating hbv infection | |
| Rehermann | Intrahepatic T cells in hepatitis B: viral control versus liver cell injury | |
| Riedl et al. | Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential | |
| Kakimi et al. | Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections | |
| Sette et al. | Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice | |
| Firat et al. | The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation | |
| Dion et al. | Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules | |
| Desmond et al. | A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics | |
| Fumagalli et al. | Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection | |
| Whitacre et al. | Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance | |
| JP2003512826A (en) | Activation of HCV-specific T cells | |
| Schirmbeck et al. | Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen | |
| Schirmbeck et al. | Targeting murine immune responses to selected T cell-or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen | |
| Schirmbeck et al. | Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross‐reactive, natural HBsAg variants | |
| Guha et al. | Cell culture and animal models of viral hepatitis. Part I: hepatitis B | |
| Webster et al. | Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection | |
| Rodriguez et al. | Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8+ T-cell populations with differing cytolytic activities | |
| Ragonnaud et al. | Therapeutic vaccine against primate papillomavirus infections of the cervix | |
| Bertoletti et al. | Therapeutic vaccination and novel strategies to treat chronic HBV infection | |
| Chen et al. | Nondeletional T-cell receptor transgenic mice: model for the CD4+ T-cell repertoire in chronic hepatitis B virus infection | |
| Schirmbeck et al. | Different immunogenicity of H‐2 Kb‐restricted epitopes in natural variants of the hepatitis B surface antigen | |
| Satoi et al. | Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins | |
| Milich et al. | Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice. | |
| Li et al. | A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice | |
| Chen et al. | Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination |